companydata.dkcompanydata.dk

Selma Diagnostics ApS: Financial statements 2025

CVR: 36961376

Source: annual report 2025, Danish Business Authority

01/01/202531/12/2025

Selma Diagnostics ApS (CVR 36961376) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -1,093,508 and a net result of DKK -3,060,808 compared with DKK -2,178,400 the year before. Equity in the 2025 report amounted to DKK -11,154,823. The company had 2 employees in the financial year.

Gross Profit
DKK -1,093,508
Profit/Loss
DKK -3,060,808
Equity
DKK -11,154,823
Total Assets
DKK 400,338
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025--1.1 mio.-3.1 mio.-11.2 mio.2
2024--1.4 mio.-2.2 mio.-8.1 mio.2
2023--1.4 mio.-1.9 mio.-5.9 mio.2
2022--1.6 mio.-2.8 mio.-4 mio.2
2021--1.8 mio.-2 mio.-1.2 mio.2

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Selma Diagnostics ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

Selma Diagnostics ApS: The 2024 annual report is outJul 2, 2025

Selma Diagnostics ApS has published its annual report for 2024. Gross profit came to DKK -1,362,633, and the net result was DKK -2,178,400.

Selma Diagnostics ApS appoints new auditorMay 19, 2025

As of May 19, 2025, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Selma Diagnostics ApS.

Auditor steps down at Selma Diagnostics ApSMay 19, 2025

As of May 19, 2025, BDO Holding VII, statsautoriseret revisionsaktieselskab has stepped down as auditor of Selma Diagnostics ApS.

About Selma Diagnostics ApS

Selma Diagnostics ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2015. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Andreas Hjarne Kunding. The board consists of Carsten Krogh Gomard (chair), Andreas Hjarne Kunding and John Alexander. The company's owners include John Alexander, CARSTEN GOMARD HOLDING ApS and Selma Diagnostics ApS. The company has 3 employees (2018). In 2025, the company reported a gross profit of DKK -1,093,508 and a net result of DKK -3,060,808 compared with DKK -2,178,400 the year before. Equity in the 2025 report amounted to DKK -11,154,823.

Source: annual report 2025, Danish Business Authority